SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS
Clinical trials for SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for lupus skin lesions
Disease control Recruiting nowThis study tests an investigational drug called IMVT-1402 in people with active lupus skin disease (subacute or chronic cutaneous lupus). About 56 participants will receive either the drug or a placebo for 12 weeks, then all will get the drug for 14 more weeks, followed by a 26-w…
Matched conditions: SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated May 26, 2026 03:41 UTC
-
New hope for lupus skin flares? drug trial targets stubborn rash
Disease control Recruiting nowThis study tests a new drug called litifilimab for people with lupus that causes painful or itchy skin rashes (cutaneous lupus). It is for those whose rashes did not improve with standard antimalarial pills. The study will compare the drug to a placebo for 24 weeks, then everyone…
Matched conditions: SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS
Phase: PHASE2, PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated May 22, 2026 14:02 UTC